Eli Lilly & Co.

NYS : LLY
Pharmaceuticals
Indianapolis Indiana
2011 Revenue (US$ Millions)$24,287
2010 Revenue (US$ Millions)$23,076
Revenue Growth (%)5.25%
Net Income (US$ Millions)$4,348
Common Shares Outstanding (Millions)$1,158
Earnings Per Share (US$)$3.90
Earnings Per Share Growth (%)-14.85%
Price To Earnings Ratio10.71
Total Equity (US$ Millions)$13,542
Profit Growth (%)-14.24
Profit Margin (%)17.90%
Return On Equity (%)35.00%
Long Term Debt (US$ Millions)$5,465
Debt To Equity Ratio (%)0.40%
Market Capitalization (US$ Millions)$48,118
Total Assets (US$ Millions)$33,660
Return on Assets (%)14.02
Current Assets (US$ Millions)$14,248
Inventories (US$ Millions)$2,300
Current Liabilities (US$ Millions)$8,931
Cost of Goods Sold (US$ Millions)$5,068
Asset Turnover0.72
Inventory Turnover2.1